CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 108 filers reported holding CHEMOCENTRYX INC in Q3 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $52,111,000 | +93.2% | 2,102,953 | +95.5% | 0.33% | +147.4% |
| Q1 2022 | $26,968,000 | -58.8% | 1,075,722 | -40.1% | 0.13% | -50.2% |
| Q4 2021 | $65,424,000 | +48.6% | 1,796,862 | -30.2% | 0.27% | +49.2% |
| Q3 2021 | $44,033,000 | -21.1% | 2,575,035 | +136.5% | 0.18% | -28.4% |
| Q1 2021 | $55,786,000 | -18.7% | 1,088,728 | -1.8% | 0.25% | -26.0% |
| Q4 2020 | $68,658,000 | +16.3% | 1,108,804 | +3.0% | 0.34% | -9.9% |
| Q3 2020 | $59,020,000 | +11.0% | 1,077,007 | +16.5% | 0.38% | -2.6% |
| Q2 2020 | $53,193,000 | +10.3% | 924,449 | -23.0% | 0.38% | -23.3% |
| Q1 2020 | $48,231,000 | -6.3% | 1,200,370 | -7.7% | 0.50% | +19.0% |
| Q4 2019 | $51,458,000 | +136.0% | 1,301,076 | -59.5% | 0.42% | +102.9% |
| Q3 2019 | $21,800,000 | -22.0% | 3,215,370 | +7.0% | 0.21% | -23.5% |
| Q2 2019 | $27,945,000 | -18.4% | 3,004,865 | +21.9% | 0.27% | -27.1% |
| Q1 2019 | $34,234,000 | +35.1% | 2,464,664 | +6.1% | 0.37% | +10.4% |
| Q4 2018 | $25,347,000 | -16.1% | 2,323,323 | -2.8% | 0.34% | -2.0% |
| Q3 2018 | $30,200,000 | -3.6% | 2,389,254 | +0.5% | 0.34% | -8.5% |
| Q2 2018 | $31,322,000 | -3.4% | 2,378,263 | -0.2% | 0.38% | -10.0% |
| Q1 2018 | $32,408,000 | +149.6% | 2,382,932 | +9.2% | 0.42% | +143.6% |
| Q4 2017 | $12,982,000 | -21.1% | 2,181,888 | -1.7% | 0.17% | -23.2% |
| Q3 2017 | $16,463,000 | -22.0% | 2,218,765 | -1.6% | 0.22% | -23.8% |
| Q2 2017 | $21,111,000 | +41.8% | 2,255,438 | +10.3% | 0.29% | +33.6% |
| Q1 2017 | $14,891,000 | -17.1% | 2,045,399 | -15.8% | 0.22% | -18.8% |
| Q4 2016 | $17,967,000 | +17.8% | 2,427,932 | -3.9% | 0.27% | +19.4% |
| Q3 2016 | $15,255,000 | +32.0% | 2,525,647 | -1.9% | 0.23% | +28.2% |
| Q2 2016 | $11,557,000 | +101.6% | 2,573,898 | +5.1% | 0.18% | +101.1% |
| Q1 2016 | $5,732,000 | -70.9% | 2,449,783 | +0.7% | 0.09% | -67.6% |
| Q4 2015 | $19,702,000 | +32.7% | 2,432,302 | -0.9% | 0.27% | +37.4% |
| Q3 2015 | $14,842,000 | -28.2% | 2,453,257 | -2.3% | 0.20% | -12.0% |
| Q2 2015 | $20,659,000 | +7.9% | 2,510,161 | -1.0% | 0.22% | +13.1% |
| Q1 2015 | $19,151,000 | +10.5% | 2,536,535 | -0.0% | 0.20% | +10.6% |
| Q4 2014 | $17,327,000 | +51.4% | 2,536,928 | -0.2% | 0.18% | +50.0% |
| Q3 2014 | $11,444,000 | -24.6% | 2,543,034 | -2.0% | 0.12% | -18.9% |
| Q2 2014 | $15,186,000 | -12.1% | 2,595,950 | -0.4% | 0.15% | -11.9% |
| Q1 2014 | $17,284,000 | +12.6% | 2,607,001 | -1.6% | 0.17% | +11.3% |
| Q4 2013 | $15,347,000 | +58.0% | 2,650,551 | +51.7% | 0.15% | +49.5% |
| Q3 2013 | $9,712,000 | -58.3% | 1,746,744 | +6.1% | 0.10% | -60.4% |
| Q2 2013 | $23,272,000 | – | 1,645,854 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |